Literature DB >> 8521742

Malaria therapy and prophylaxis with cotrifazid, a multiple complex combination consisting of rifampicin + isoniazid + sulfamethoxazole + trimethoprim.

E Freerksen1, E W Kanthumkumwa, A R Kholowa.   

Abstract

This report contains the first therapeutic results with the multiple combination rifampicin + isoniazid + sulfamethoxazole + trimethoprim in the treatment of malaria. Clinical symptoms declined rapidly and parasites were cleared from the erythrocytes. Tolerance was excellent. This fixed combination is outstandingly practicable, with few problems with compliance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521742     DOI: 10.1159/000239372

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  2 in total

1.  Rifampicin/Cotrimoxazole/Isoniazid versus mefloquine or quinine + sulfadoxine- pyrimethamine for malaria: a randomized trial.

Authors:  Blaise Genton; Ivo Mueller; Inoni Betuela; Gerard Casey; Meza Ginny; Michael P Alpers; John C Reeder
Journal:  PLoS Clin Trials       Date:  2006-12-22

Review 2.  Repurposing Drugs to Fight Hepatic Malaria Parasites.

Authors:  Diana Fontinha; Isabel Moules; Miguel Prudêncio
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.